SG11201405433XA - Basal insulin therapy - Google Patents

Basal insulin therapy

Info

Publication number
SG11201405433XA
SG11201405433XA SG11201405433XA SG11201405433XA SG11201405433XA SG 11201405433X A SG11201405433X A SG 11201405433XA SG 11201405433X A SG11201405433X A SG 11201405433XA SG 11201405433X A SG11201405433X A SG 11201405433XA SG 11201405433X A SG11201405433X A SG 11201405433XA
Authority
SG
Singapore
Prior art keywords
basal insulin
insulin therapy
therapy
basal
insulin
Prior art date
Application number
SG11201405433XA
Inventor
Peter Johnston
Hertzel Gerstein
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SG11201405433XA publication Critical patent/SG11201405433XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
SG11201405433XA 2012-03-28 2013-03-28 Basal insulin therapy SG11201405433XA (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261616768P 2012-03-28 2012-03-28
US201261619641P 2012-04-03 2012-04-03
US201261624598P 2012-04-16 2012-04-16
US201261645909P 2012-05-11 2012-05-11
US201261701911P 2012-09-17 2012-09-17
PCT/EP2013/056661 WO2013144273A1 (en) 2012-03-28 2013-03-28 Basal insulin therapy

Publications (1)

Publication Number Publication Date
SG11201405433XA true SG11201405433XA (en) 2014-10-30

Family

ID=48044781

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201405433XA SG11201405433XA (en) 2012-03-28 2013-03-28 Basal insulin therapy

Country Status (13)

Country Link
US (1) US20150065421A1 (en)
EP (1) EP2830650A1 (en)
JP (1) JP2015512908A (en)
KR (1) KR20150001757A (en)
CN (1) CN104334183A (en)
AU (1) AU2013241776B2 (en)
CA (1) CA2865823A1 (en)
HK (1) HK1201155A1 (en)
IN (1) IN2014KN02335A (en)
MX (1) MX2014011687A (en)
RU (1) RU2014143271A (en)
SG (1) SG11201405433XA (en)
WO (1) WO2013144273A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180369342A1 (en) * 2015-12-23 2018-12-27 Sanofi-Aventis Deutschland Gmbh Cardiac metabolic effect of lantus
US11673933B2 (en) 2016-11-28 2023-06-13 Novo Nordisk A/S Method for using insulin degludec for the improvement of glycemic control and reduction of acute and long-term diabetes complications
WO2018096164A1 (en) * 2016-11-28 2018-05-31 Novo Nordisk A/S Insulin degludec for treating diabetes
JP7193455B2 (en) * 2016-11-28 2022-12-20 ノヴォ ノルディスク アー／エス Insulin degludec in cardiovascular conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0309154D0 (en) * 2003-01-14 2003-05-28 Aventis Pharma Inc Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia
EA201991014A1 (en) * 2010-06-24 2019-09-30 Бёрингер Ингельхайм Интернациональ Гмбх DIABETES TREATMENT

Also Published As

Publication number Publication date
CA2865823A1 (en) 2013-10-03
RU2014143271A (en) 2016-05-20
WO2013144273A1 (en) 2013-10-03
AU2013241776A1 (en) 2014-10-16
MX2014011687A (en) 2015-05-11
CN104334183A (en) 2015-02-04
KR20150001757A (en) 2015-01-06
HK1201155A1 (en) 2015-08-28
EP2830650A1 (en) 2015-02-04
US20150065421A1 (en) 2015-03-05
JP2015512908A (en) 2015-04-30
IN2014KN02335A (en) 2015-05-01
AU2013241776B2 (en) 2017-11-02

Similar Documents

Publication Publication Date Title
IL272915B (en) Syringe
HK1202816A1 (en) Syringe
EP2832391A4 (en) Syringe
GB2500092B (en) Syringe
HK1251496A1 (en) Syringe
EP2913076A4 (en) Syringe
HK1201155A1 (en) Basal insulin therapy
GB201213522D0 (en) Single use syringe
GB201213521D0 (en) Single use syringe
EP2885023A4 (en) Syringe
PT3381444T (en) Syringe